author: hubing shi

Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies

Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
Jie XuHubing ShiHuan Meng
Science
... (CheckMate 032): a multicentre, open-label, phase 1/2 trial. Lancet Oncol. 17 ... combination with ipilimumab in small-cell lung cancer. Cancer Cell. 33853-861 ... 1000. doi: 10.1200/JCO.18.01042 Sharma, P., Siefker-Radtke, A., De Braud, F ...
Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer and esophageal cancer, volume II

Community series in immunotherapy with checkpoint inhibitors for non-small cell lung cancer, colon cancer and esophageal cancer, volume II
Xuelei MaBenjamin FreyUdo S. GaiplHubing Shi
Medical
... hyperthermia, causing the release of tumor-associated antigens and DMAPs ... (NCP@pyrolipid) which not only directly eliminated tumor cells but also ... NCP@pyrolipid, tumor regression was observed in both light-irradiated primary tumors ...
Public Health, Public Health Education, and their Future Prospects

Public Health, Public Health Education, and their Future Prospects
Xuelei MaHubing ShiYihui DuWenhao Cai
Medical
... pharmacy students had studied A - level maths before entering into pharmacy courses which are in line with the study done in Northern Ireland ( 14 ) . N = 529 ( % ) 461 ( 87.1 ) 68 ( 12.9 ) Did you learn about numeracy ? ( mathematical ...

© 2024 www.zuuk.org. All rights reserved.

This website uses cookies and collects data for optimal performance. Your continued use signifies agreement to our Privacy Policy.